Two Sigma Advisers LP raised its position in shares of Cutera, Inc. (NASDAQ:CUTR) by 2.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 55,827 shares of the medical device company’s stock after acquiring an additional 1,357 shares during the period. Two Sigma Advisers LP’s holdings in Cutera were worth $950,000 at the end of the most recent reporting period.
Other hedge funds have also recently bought and sold shares of the company. Bank of New York Mellon Corp grew its stake in Cutera by 3.1% in the third quarter. Bank of New York Mellon Corp now owns 159,055 shares of the medical device company’s stock valued at $5,178,000 after purchasing an additional 4,810 shares during the last quarter. BlackRock Inc. lifted its holdings in Cutera by 6.6% in the third quarter. BlackRock Inc. now owns 2,024,978 shares of the medical device company’s stock valued at $65,914,000 after acquiring an additional 126,213 shares during the period. Man Group plc lifted its holdings in Cutera by 3.5% in the third quarter. Man Group plc now owns 114,629 shares of the medical device company’s stock valued at $3,731,000 after acquiring an additional 3,826 shares during the period. MetLife Investment Advisors LLC lifted its holdings in Cutera by 54.6% in the third quarter. MetLife Investment Advisors LLC now owns 10,424 shares of the medical device company’s stock valued at $339,000 after acquiring an additional 3,680 shares during the period. Finally, Marshall Wace LLP acquired a new position in Cutera in the third quarter valued at approximately $489,000. 94.00% of the stock is owned by hedge funds and other institutional investors.
Shares of NASDAQ:CUTR opened at $17.97 on Monday. The firm has a market capitalization of $252.54 million, a price-to-earnings ratio of -8.06 and a beta of 0.73. Cutera, Inc. has a 52-week low of $12.32 and a 52-week high of $56.05.
Cutera (NASDAQ:CUTR) last issued its earnings results on Wednesday, February 20th. The medical device company reported ($0.11) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.03 by ($0.14). The company had revenue of $45.47 million during the quarter, compared to analysts’ expectations of $44.29 million. Cutera had a negative net margin of 18.91% and a negative return on equity of 48.46%. The firm’s quarterly revenue was down 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.42 earnings per share. As a group, equities research analysts anticipate that Cutera, Inc. will post -0.33 earnings per share for the current year.
CUTR has been the subject of a number of analyst reports. Maxim Group reissued a “hold” rating on shares of Cutera in a report on Tuesday, January 8th. ValuEngine cut Cutera from a “strong-buy” rating to a “buy” rating in a research report on Thursday, December 20th. TheStreet cut Cutera from a “c” rating to a “d” rating in a research report on Thursday, February 21st. BidaskClub upgraded Cutera from a “hold” rating to a “buy” rating in a report on Friday, March 22nd. Finally, Zacks Investment Research cut Cutera from a “hold” rating to a “strong sell” rating in a report on Friday, January 4th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $34.67.
TRADEMARK VIOLATION NOTICE: This story was published by Macon Daily and is the sole property of of Macon Daily. If you are viewing this story on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this story can be accessed at https://macondaily.com/2019/04/15/two-sigma-advisers-lp-boosts-holdings-in-cutera-inc-cutr.html.
Cutera Company Profile
Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.
Read More: Using the New Google Finance Tool
Want to see what other hedge funds are holding CUTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cutera, Inc. (NASDAQ:CUTR).
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.